Page 1 of Clinical Trials for "Heredodegenerative Disorders, Nervous System", 443 Total Matches
- 1CompletedLast Updated: August 27, 2009Condition(s): Familial Dementia With Neuroserpin Inclusion Bodies; Nervous System Heredodegenerative Disorder
- 2CompletedLast Updated: March 13, 2012Condition(s): Huntington's Disease
- 3RecruitingLast Updated: March 13, 2012Condition(s): Huntington's Disease
- 4Enrolling by invitationLast Updated: June 9, 2009Condition(s): Congenital Vertical Talus; Familial Encephalopathy With Neuroserpin Inclusion Bodies; Idiopathic Generalised Epilepsy; Familial Dementia; X-Linked Mental Retardation
- 5Active, not recruitingLast Updated: June 23, 2005Condition(s): I Cell Disease; Fucosidosis; Globoid Cell Leukodystrophy; Adrenoleukodystrophy; Mannosidosis; Niemann-Pick Disease; Pulmonary Complications; Mucopolysaccharidosis I; Mucopolysaccharidosis VI; Metachromatic Leukodystrophy; Gaucher's Disease; Wolman Disease
- 6CompletedLast Updated: March 3, 2008Condition(s): Tourette's Syndrome; Chronic Motor Tic Disorder; Chronic Motor Vocal Disorder
- 7CompletedLast Updated: January 18, 2011Condition(s): Gilles de la Tourette's Syndrome
- 8Active, not recruitingLast Updated: October 13, 2011Condition(s): Tuberous Sclerosis Complex (TSC); Lymphangioleiomyomatosis (LAM)
- 9Active, not recruitingLast Updated: August 10, 2011Condition(s): Spinal Muscular Atrophy Type II; Spinal Muscular Atrophy Type III Non Ambulant
- 10RecruitingLast Updated: May 2, 2012Condition(s): Tourette Disorder; Tourette Syndrome
- 11CompletedLast Updated: May 17, 2012Condition(s): Huntington Disease
- 12TerminatedLast Updated: July 14, 2010Condition(s): Tourette Syndrome
- 13CompletedLast Updated: February 24, 2012Condition(s): Tuberous Sclerosis; Neurofibromatoses; Angiofibroma; Neurofibroma
- 14RecruitingLast Updated: April 11, 2012Condition(s): Motor Neuron Disease
- 15Not yet recruitingLast Updated: May 17, 2012Condition(s): Mucopolysaccharidosis II
- 16CompletedLast Updated: August 30, 2011Condition(s): Neurofibromatosis 1; Neurofibroma, Plexiform
- 17Completed
- 18Active, not recruitingA Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy PatientsLast Updated: December 2, 2008Condition(s): Muscular Atrophy, Spinal
- 19CompletedLast Updated: May 26, 2010Condition(s): Friedreich's Ataxia
- 20RecruitingLast Updated: March 31, 2010Condition(s): Neurofibromatosis Type 1; Cutaneous Neurofibromas
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?cond=%22Heredodegenerative+Disorders%2C+Nervous+System%22
